查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390573

抗凝血剂市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Anticoagulants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球抗凝血剂市场规模达到374亿美元展望未来， IMARC Group预计到2028年市场规模将达到670亿美元，2022-2028年复合年增长率（CAGR）为10.20%。血栓性疾病病例的增加、久坐的生活方式以及医疗保健产业的改善是推动市场发展的一些关键因素。

抗凝血剂是防止血栓形成并减少中风和心臟病等严重疾病的机会的药物。它们有助于治疗现有的阻碍血管流动的血栓，防止血栓变大，并降低严重併发症的风险。它们有不同的规格和颜色，有口服剂型（如片剂和胶囊）和注射剂型。目前，由于直接口服抗凝血剂（DOAc）易于使用且无需常规监测，越来越多的人开始使用直接口服抗凝血剂。

抗凝血剂市场趋势：

全球老年人口不断增长，人类免疫缺陷病毒（HIV）、莱姆病、肥胖、C型肝炎、慢性发炎和心血管疾病的盛行率不断上升，是对全球市场产生积极影响的关键因素之一。此外，由于久坐的生活方式和忙碌的工作安排，导致肺栓塞（PE）等血栓性疾病病例不断增加，导致全球心臟相关疾病的增加。此外，久坐、吸烟、外伤、血液疾病和自体免疫疾病正在增加身体不同部位血液凝固的风险，这反过来又促进了对抗凝剂的需求。除此之外，药物发现的研发（R＆D）活动不断进步，以及人工智慧（AI）和机器学习（ML）等先进技术的集成，以分析大量资料，识别潜在的候选药物并开发一种新药正在推动市场成长。据此，医疗保健提供者正在专注于根据个别患者的遗传和临床资料进行个人化抗凝血治疗。人工智慧有助于确定患者最有效的抗凝血剂剂量和类型，从而降低併发症风险并改善预后。此外，非营利组织为提高心血管健康意识而采取的有利倡议，以及各国政府和公共卫生机构之间为预防心臟病和中风而不断加强的伙伴关係，正在推动全球市场的成长。其他因素，如蓬勃发展的医疗保健行业以及药品的可负担性和可及性的提高，正在刺激市场的成长。

本报告回答的关键问题

  • 2022年全球抗凝血剂市场规模有多大？
  • 2023-2028年全球抗凝血剂市场的预期成长率是多少？
  • 推动全球抗凝血剂市场的关键因素是什么？
  • COVID-19 对全球抗凝血剂市场有何影响？
  • 根据药物类别，全球抗凝血剂市场的细分情况如何？
  • 根据给药途径，全球抗凝血剂市场的细分情况如何？
  • 全球抗凝血剂市场按配销通路划分是怎样的？
  • 根据应用，全球抗凝血剂市场的细分情况如何？
  • 全球抗凝血药市场的重点区域有哪些？
  • 全球抗凝血剂市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球抗凝血剂市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按药物类别分類的市场细分

  • 新型口服抗凝血剂（NOAC）
    • 市场走向
    • 市场预测
  • 肝素和低分子肝素 (LMWH)
    • 市场走向
    • 市场预测
  • 维生素K拮抗剂
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：按管理途径分類的市场

  • 口服抗凝血剂
    • 市场走向
    • 市场预测
  • 注射抗凝血剂
    • 市场走向
    • 市场预测

第 8 章：按配销通路分類的市场区隔

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 网上商店
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按应用分類的市场区隔

  • 心房颤动和心臟病发作
    • 市场走向
    • 市场预测
  • 中风
    • 市场走向
    • 市场预测
  • 深部静脉血栓 (DVT)
    • 市场走向
    • 市场预测
  • 肺栓塞（PE）
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Alexion Pharmaceuticals Inc
    • Aspen Holdings
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • Daiichi Sankyo Company Limited
    • Dr. Reddy's Laboratories Ltd
    • GlaxoSmithKline plc
    • Johnson & Johnson Private Limited
    • Pfizer Inc.
    • Sanofi
Product Code: SR112023A4360

Abstract

The global anticoagulants market size reached US$ 37.4 Billion in 2022 Looking forward, IMARC Group expects the market to reach US$ 67.0 Billion by 2028, exhibiting a growth rate (CAGR) of 10.20% during 2022-2028. The rising cases of thrombotic disorders, sedentary lifestyles, and the improving healthcare sector represent some of the key factors driving the market.

Anticoagulants are medicines that prevent the formation of blood clots and reduce the chances of developing severe conditions, such as strokes and heart attacks. They assist in treating existing blood clots that resist the flow of blood through vessels and prevent them from getting larger and reducing the risk of serious complications. They are available in different strengths and colors and as oral, such as tablets and capsules, and injectable variants. At present, direct oral anticoagulants (DOAc) are increasingly being prescribed on account of their ease of use and lack of need for routine monitoring.

Anticoagulants Market Trends:

The growing geriatric population and increasing prevalence of human immunodeficiency virus (HIV), lyme disease, obesity, hepatitis C, chronic inflammation, and cardiovascular disorders across the globe represent one of the key factors positively influencing the market across the globe. In addition, rising cases of thrombotic disorders, such as pulmonary embolism (PE), on account of sedentary lifestyles and hectic work schedules are inducing the growth of heart-related diseases worldwide. Moreover, extended sitting, smoking, trauma, blood disorders, and autoimmune diseases are increasing the risk of blood clotting in different parts of the body, which, in turn, is catalyzing the demand for anticoagulants. Apart from this, increasing advancements in research and development (R&D) activities in drug discovery and the integration of advanced technologies, such as artificial intelligence (AI) and machine learning (ML) to analyze large amounts of data, identify potential drug candidates and develop a new drug is fueling the market growth. In line with this, healthcare providers are focusing on personalizing anticoagulant therapy for individual patients based on their genetic and clinical data. AI assists in identifying the most effective dose and type of anticoagulant for the patient, which, in turn, reduces the risk of complications and improves outcomes. Furthermore, favorable initiatives by non-profitable organizations to promote awareness about cardiovascular health and the growing partnerships between governments of various countries and public health agencies to prevent heart disease and strokes are propelling the growth of the market worldwide. Other factors like the burgeoning healthcare sector and increasing affordability and accessibility of drugs are stimulating the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global anticoagulants market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class, route of administration, distribution channel and application.

Drug Class Insights:

Novel Oral Anticoagulants (NOACs)

Heparin and Low Molecular Weight Heparin (LMWH)

Vitamin K Antagonist

Others

The report has provided a detailed breakup and analysis of the anticoagulants market based on the drug class. This includes novel oral anticoagulants (NOACs), heparin and low molecular weight heparin (LMWH), vitamin K antagonist, and others. According to the report, novel oral anticoagulants (NOACs) represented the largest segment.

Route of Administration Insights:

Oral Anticoagulant

Injectable Anticoagulant

A detailed breakup and analysis of the anticoagulants market based on the route of administration has also been provided in the report. This includes oral anticoagulant and injectable anticoagulant. According to the report, oral anticoagulant accounted for the largest market share.

Distribution Channel Insights:

Hospital Pharmacies

Retail Pharmacies

Online Stores

Others

A detailed breakup and analysis of the anticoagulants market based on the distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, online stores, and others. According to the report, hospital pharmacies accounted for the largest market share.

Application Insights:

Atrial Fibrillation and Heart Attack

Stroke

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Others

A detailed breakup and analysis of the anticoagulants market based on the application has also been provided in the report. This includes atrial fibrillation and heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and others. According to the report, atrial fibrillation and heart attack accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for anticoagulants. Some of the factors driving the North America anticoagulants market included the increasing prevalence of thrombotic disorders, developed healthcare sector, ongoing research and development (R&D) activities in drug discovery etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global anticoagulants market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alexion Pharmaceuticals Inc, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc., Sanofi, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global anticoagulants market in 2022?
  • 2. What is the expected growth rate of the global anticoagulants market during 2023-2028?
  • 3. What are the key factors driving the global anticoagulants market?
  • 4. What has been the impact of COVID-19 on the global anticoagulants market?
  • 5. What is the breakup of the global anticoagulants market based on the drug class?
  • 6. What is the breakup of the global anticoagulants market based on the route of administration?
  • 7. What is the breakup of the global anticoagulants market based on the distribution channel?
  • 8. What is the breakup of the global anticoagulants market based on the application?
  • 9. What are the key regions in the global anticoagulants market?
  • 10. Who are the key players/companies in the global anticoagulants market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anticoagulants Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Novel Oral Anticoagulants (NOACs)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Heparin and Low Molecular Weight Heparin (LMWH)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Vitamin K Antagonist
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral Anticoagulant
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Injectable Anticoagulant
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Atrial Fibrillation and Heart Attack
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Stroke
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Deep Vein Thrombosis (DVT)
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Pulmonary Embolism (PE)
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Alexion Pharmaceuticals Inc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Aspen Holdings
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Boehringer Ingelheim International GmbH
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Bristol-Myers Squibb Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Daiichi Sankyo Company Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Dr. Reddy's Laboratories Ltd
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 GlaxoSmithKline plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Johnson & Johnson Private Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Anticoagulants Market: Major Drivers and Challenges
  • Figure 2: Global: Anticoagulants Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Anticoagulants Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Anticoagulants Market: Breakup by Drug Class (in %), 2022
  • Figure 5: Global: Anticoagulants Market: Breakup by Route of Administration (in %), 2022
  • Figure 6: Global: Anticoagulants Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Anticoagulants Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Anticoagulants Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Anticoagulants (Vitamin K Antagonist) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Anticoagulants (Vitamin K Antagonist) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Anticoagulants (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Anticoagulants (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Anticoagulants (Oral Anticoagulant) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Anticoagulants (Oral Anticoagulant) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Anticoagulants (Injectable Anticoagulant) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Anticoagulants (Injectable Anticoagulant) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Anticoagulants (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Anticoagulants (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Anticoagulants (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Anticoagulants (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Anticoagulants (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Anticoagulants (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Anticoagulants (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Anticoagulants (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Anticoagulants (Stroke) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Anticoagulants (Stroke) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Anticoagulants (Pulmonary Embolism-PE) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Anticoagulants (Pulmonary Embolism-PE) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Anticoagulants (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Anticoagulants (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: North America: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: North America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: United States: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: United States: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Canada: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Canada: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia-Pacific: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Asia-Pacific: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: China: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: China: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Japan: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Japan: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: India: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: India: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: South Korea: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: South Korea: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Australia: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Australia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Indonesia: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Indonesia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Europe: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Europe: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Germany: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Germany: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: France: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: France: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: United Kingdom: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: United Kingdom: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Italy: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Italy: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Spain: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Spain: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Russia: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Russia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Latin America: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Latin America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Brazil: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Brazil: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Mexico: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Mexico: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Others: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Middle East and Africa: Anticoagulants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Middle East and Africa: Anticoagulants Market: Breakup by Country (in %), 2022
  • Figure 87: Middle East and Africa: Anticoagulants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Anticoagulants Industry: SWOT Analysis
  • Figure 89: Global: Anticoagulants Industry: Value Chain Analysis
  • Figure 90: Global: Anticoagulants Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anticoagulants Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Anticoagulants Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
  • Table 3: Global: Anticoagulants Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 4: Global: Anticoagulants Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Anticoagulants Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Anticoagulants Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Anticoagulants Market: Competitive Structure
  • Table 8: Global: Anticoagulants Market: Key Players